HCA Healthcare, Inc. (HCA)
NYSE: HCA · IEX Real-Time Price · USD
323.44
+0.57 (0.18%)
May 20, 2024, 2:45 PM EDT - Market open

HCA Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2008
Revenue
64,96860,23358,75251,53351,336
Upgrade
Revenue Growth (YoY)
7.86%2.52%14.01%0.38%9.98%
Upgrade
Cost of Revenue
39,38937,05636,26032,24332,041
Upgrade
Gross Profit
25,57923,17722,49219,29019,295
Upgrade
Other Operating Expenses
15,95214,12412,81412,02812,077
Upgrade
Operating Expenses
15,95214,12412,81412,02812,077
Upgrade
Operating Income
9,6279,0539,6787,2627,218
Upgrade
Interest Expense / Income
1,9381,7411,5661,5841,824
Upgrade
Other Expense / Income
832-77-956881790
Upgrade
Pretax Income
6,8577,3899,0684,7974,604
Upgrade
Income Tax
1,6151,7462,1121,0431,099
Upgrade
Net Income
5,2425,6436,9563,7543,505
Upgrade
Net Income Growth
-7.11%-18.88%85.30%7.10%-7.45%
Upgrade
Shares Outstanding (Basic)
272290323338341
Upgrade
Shares Outstanding (Diluted)
276295329344348
Upgrade
Shares Change
-6.19%-10.37%-4.32%-1.33%-1.99%
Upgrade
EPS (Basic)
19.2519.4321.5211.1010.27
Upgrade
EPS (Diluted)
18.9719.1521.1610.9310.07
Upgrade
EPS Growth
-0.94%-9.50%93.60%8.54%-5.53%
Upgrade
Free Cash Flow
4,6874,1275,3826,3973,444
Upgrade
Free Cash Flow Per Share
17.2114.2116.6518.9110.09
Upgrade
Dividend Per Share
2.4002.2401.9200.7701.600
Upgrade
Dividend Growth
7.14%16.67%149.35%-51.88%14.29%
Upgrade
Gross Margin
39.37%38.48%38.28%37.43%37.59%
Upgrade
Operating Margin
14.82%15.03%16.47%14.09%14.06%
Upgrade
Profit Margin
8.07%9.37%11.84%7.28%6.83%
Upgrade
Free Cash Flow Margin
7.21%6.85%9.16%12.41%6.71%
Upgrade
Effective Tax Rate
23.55%23.63%23.29%21.74%23.87%
Upgrade
EBITDA
11,87212,09913,4879,1029,024
Upgrade
EBITDA Margin
18.27%20.09%22.96%17.66%17.58%
Upgrade
Depreciation & Amortization
3,0772,9692,8532,7212,596
Upgrade
EBIT
8,7959,13010,6346,3816,428
Upgrade
EBIT Margin
13.54%15.16%18.10%12.38%12.52%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).